Faithward Advisors’s Pacific Biosciences PACB Stock Holding History

Faithward Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$56.1K	–	311
2025 Q4	$56.1K	Hold	30,000	–	–	0.01%	326
2025 Q3	$38.4K	Hold	30,000	–	–	0.01%	303
2025 Q2	$37.2K	Hold	30,000	–	–	0.01%	264
2025 Q1	$35.4K	Hold	30,000	–	–	0.01%	259
2024 Q4	$54.9K	Hold	30,000	–	–	0.01%	251
2024 Q3	$51K	Hold	30,000	–	–	0.01%	278
2024 Q2	$41.1K	Hold	30,000	–	–	0.01%	250
2024 Q1	$113K	Hold	30,000	–	–	0.02%	249
2023 Q4	$193K	Buy	30,000 +7,000	+30%	+$57.2K	0.04%	166
2023 Q3	$148K	Buy	23,000 +4,000	+21%	+$45.7K	0.04%	162
2023 Q2	$219K	Buy	19,000 +1,000	+6%	+$12.2K	0.05%	158
2023 Q1	$219K	Hold	18,000	–	–	0.05%	173
2022 Q4	$147K	Hold	18,000	–	–	0.03%	151
2022 Q3	$104K	Hold	18,000	–	–	0.02%	144
2022 Q2	$80K	Hold	18,000	–	–	0.02%	170
2022 Q1	$164K	Buy	18,000 +5,000	+38%	+$57.6K	0.03%	163
2021 Q4	$266K	Sell	13,000 -7,500	-37%	-$181K	0.05%	140
2021 Q3	$524K	Buy	20,500 +9,500	+86%	+$281K	0.1%	102
2021 Q2	$385K	Buy	+11,000	New	+$320K	0.08%	116
2021 Q1	–	Sell	-11,000	Closed	-$285K	–	254
2020 Q4	$285K	Sell	11,000 -11,500	-51%	-$195K	0.12%	67
2020 Q3	$222K	Buy	+22,500	New	+$130K	0.05%	127

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Faithward Advisors's PACB Position: Q1 2026 in Review

Faithward Advisors sold out of Pacific Biosciences (PACB) in Q1 2026, closing a stake of 30,000 shares — an estimated $56.1K sold.

Faithward Advisors first reported a position in PACB in Q3 2020 and held it in 21 quarters. The position peaked at $524K in Q3 2021. 231 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Faithward Advisors reported no remaining Pacific Biosciences position as of Q1 2026 after selling out during the quarter.
Faithward Advisors sold 30,000 Pacific Biosciences shares in Q1 2026, an estimated $56.1K.
Faithward Advisors first reported a position in Pacific Biosciences in Q3 2020 and held it in 21 quarters.
Faithward Advisors's Pacific Biosciences position peaked at $524K in Q3 2021.
231 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.